WhichRecall
Class IIReported 2025-10-15

Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord Healthcare, Inc., Raleigh, NC 27617, Manufactured by: Intas Pharmaceuticals Limited, Camp Road, Selaqui, Dehradun-248 197, India, NDC 16729-450-15.

Recalled by ACCORD HEALTHCARE, INC.

Reason for Recall

Subpotent: During long term stability testing of Levothyroxine Sodium Tablets USP for 88 mcg, the assay content was observed below the approved specification range.

Advertisement
Recall Number
D-0006-2026
Classification
Class II
Status
Ongoing
Category
drug
Initiated
2025-09-16
Reported
2025-10-15
Distribution
Nationwide in the US
Code Info
Lot # D2300045, Exp 12/31/2025.
Source: openFDA enforcement report. WhichRecall is not affiliated with the FDA. See our disclaimer.
Advertisement